No Data
Morphic Fund Navigates Ethical Investing Amid Market Volatility
Morphic to Participate in RBC Capital Markets Global Healthcare Conference
WALTHAM, Mass., May 09, 2024 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biotechnology company developing a new generation of oral integrin therapies for the treatment of serious chron
Morphic Ethical Continues Share Buy-Back
Morphic Fund Advances Share Buy-Back Effort
Morphic Ethical Fund Continues Stock Buy-Back
Future Generation's Holdings Decrease in Morphic Fund